MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis
LM Janssen, BM Den Dekker, KGA Gilhuijs… - NPJ Breast …, 2022 - nature.com
This meta-analysis aimed to estimate and compare sensitivity, specificity, positive-(PPV) and
negative predictive value (NPV) of magnetic resonance imaging (MRI) for predicting …
negative predictive value (NPV) of magnetic resonance imaging (MRI) for predicting …
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast …
T Fukuda, R Horii, N Gomi, Y Miyagi, S Takahashi, Y Ito… - Springerplus, 2016 - Springer
A pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is a signature
of favorable prognosis in breast cancer. The aim of this study was to assess the accuracy of …
of favorable prognosis in breast cancer. The aim of this study was to assess the accuracy of …
[HTML][HTML] The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different …
X Zhang, D Wang, Z Liu, Z Wang, Q Li… - … Imaging in Medicine …, 2020 - ncbi.nlm.nih.gov
Background Patients treated with neoadjuvant chemotherapy (NAC) who achieve a
pathologic complete response (pCR) can be identified preoperatively and can potentially be …
pathologic complete response (pCR) can be identified preoperatively and can potentially be …
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational …
JF De Los Santos, A Cantor, KD Amos, A Forero… - Cancer, 2013 - Wiley Online Library
BACKGROUND: Increased pathologic complete response (pCR) rates observed with
neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer …
neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer …
Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes
J Kim, BK Han, EY Ko, ES Ko, JS Choi, KW Park - European Radiology, 2022 - Springer
Objectives This study aimed to investigate the predictability of breast MRI for pathologic
complete response (pCR) by molecular subtype in patients with breast cancer receiving …
complete response (pCR) by molecular subtype in patients with breast cancer receiving …
Discrepancies between pathological tumor responses and estimations of complete response by magnetic resonance imaging after neoadjuvant chemotherapy differ …
M Namura, H Tsunoda, H Yagata, N Hayashi… - Clinical Breast …, 2018 - Elsevier
Introduction The influence of breast cancer (BC) subtype in discrepancies between
pathologic complete response (pCR) and complete response by magnetic resonance …
pathologic complete response (pCR) and complete response by magnetic resonance …
Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy
EMS Negrão, JA Souza, EF Marques… - European Journal of …, 2019 - Elsevier
Purpose To evaluate which factors may influence magnetic resonance imaging (MRI)
performance in the detection of pathologic complete response (pCR) after neoadjuvant …
performance in the detection of pathologic complete response (pCR) after neoadjuvant …
MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer
SF Sener, RE Sargent, C Lee… - Journal of surgical …, 2019 - Wiley Online Library
Background This study assessed whether magnetic resonance imaging (MRI) could
accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy …
accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy …
MRI performance in detecting pCR after neoadjuvant chemotherapy by molecular subtype of breast cancer
N Yu, VWY Leung, S Meterissian - World journal of surgery, 2019 - Springer
Background MRI performance in detecting pathologic complete response (pCR) post-
neoadjuvant chemotherapy (NAC) in breast cancer has been previously explored. However …
neoadjuvant chemotherapy (NAC) in breast cancer has been previously explored. However …
Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy
J De Los Santos, W Bernreuter, K Keene… - Clinical breast …, 2011 - Elsevier
Background Prior studies of the ability of magnetic resonance imaging (MRI) to predict
pathologic response to neoadjuvant chemotherapy have shown conflicting results that vary …
pathologic response to neoadjuvant chemotherapy have shown conflicting results that vary …
相关搜索
- breast cancer neoadjuvant chemotherapy
- meta analysis neoadjuvant chemotherapy
- mri in patients neoadjuvant chemotherapy
- molecular subtype neoadjuvant chemotherapy
- pathologic response neoadjuvant chemotherapy
- breast cancer molecular subtype
- breast cancer mri in patients
- mri in patients molecular subtypes
- breast cancer pathologic response
- radiomics of mri pathological response
- diagnostic accuracy neoadjuvant chemotherapy
- breast cancer diagnostic accuracy
- complete response neoadjuvant chemotherapy
- radiomics of mri neoadjuvant chemotherapy
- mri for the prediction neoadjuvant chemotherapy
- mri performance neoadjuvant chemotherapy